Frailty, inflammation, and cardiovascular disease: Evidence of a connection

被引:0
|
作者
Phan, Huy M. [2 ,4 ]
Alpert, Joseph S. [2 ]
Fain, Mindy [1 ,2 ,3 ]
机构
[1] Univ Arizona, Coll Med, Arizona Ctr Aging, Tucson, AZ 85719 USA
[2] Univ Arizona, Coll Med, Dept Med, Tucson, AZ USA
[3] Univ Arizona, Coll Med, Sect Geriatr & Gerontol, Tucson, AZ USA
[4] Univ Calif San Diego, Div Cardiol, San Diego, CA 92103 USA
来源
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Frailty is a progressive physiologic decline in multiple body systems marked by loss of function, loss of physiologic reserve, and increased vulnerability to disease and death. Until recently, frailty has been poorly defined in the medical literature. One currently accepted definition of frailty is having 3 of the following 5 attributes: unintentional weight loss, muscle weakness, slow walking speed, easy exhaustion, and low physical activity. The mechanisms that underline frailty remain unclear. Significantly higher levels of markers of inflammation and the clotting cascade have been found in frail persons compared with nonfrail persons. These markers are also risk factors for the development of coronary heart disease. Recent research has indicated that frailty is a clinical manifestation of cardiovascular disease, especially of heart failure. Thus, understanding the connection between frailty and cardiovascular disease may lead to development of new interventions that will prevent and reverse the associated morbidity and mortality.
引用
收藏
页码:101 / 107
页数:7
相关论文
共 50 条
  • [41] Combating Inflammation in Cardiovascular Disease
    Sethwala, Anver M.
    Goh, Ian
    Amerena, John, V
    [J]. HEART LUNG AND CIRCULATION, 2021, 30 (02): : 197 - 206
  • [42] The Role of Inflammation in Cardiovascular Disease
    Henein, Michael Y.
    Vancheri, Sergio
    Longo, Giovanni
    Vancheri, Federico
    [J]. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES, 2022, 23 (21)
  • [43] Genomics and Inflammation in Cardiovascular Disease
    Dhande, Isha S.
    Doris, Peter A.
    [J]. COMPREHENSIVE PHYSIOLOGY, 2021, 11 (04) : 2433 - 2454
  • [44] Polyphenols, Inflammation, and Cardiovascular Disease
    Tangney, Christy C.
    Rasmussen, Heather E.
    [J]. CURRENT ATHEROSCLEROSIS REPORTS, 2013, 15 (05)
  • [45] Statins and Inflammation in Cardiovascular Disease
    Vogiatzi, Georgia
    Oikonomou, Evangelos
    Siasos, Gerasimos
    Tsalamandris, Sotiris
    Briasoulis, Alexandros
    Androulakis, Emmanuel
    Latsios, George
    Papaioannou, Spyridon
    Tsioufis, Konstantinos
    Tousoulis, Dimitris
    [J]. CURRENT PHARMACEUTICAL DESIGN, 2017, 23 (46) : 7027 - 7039
  • [46] Inflammation and Cardiovascular Disease: The Future
    Arnold, Natalie
    Lechner, Katharina
    Waldeyer, Christoph
    Shapiro, Michael D.
    Koenig, Wolfgang
    [J]. EUROPEAN CARDIOLOGY REVIEW, 2021, 16
  • [47] Inflammation and Cardiovascular Disease in Diabetes
    Shah, Manasi S.
    [J]. CLINICAL DIABETOLOGY, 2023, 12 (03): : 139 - 140
  • [48] The role of inflammation in cardiovascular disease
    Kuller, LH
    Tracy, RP
    [J]. ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY, 2000, 20 (04) : 901 - 901
  • [49] Targeting Inflammation in Cardiovascular Disease
    Deftereos, Spyridon
    Bouras, Georgios
    [J]. MEDICINAL CHEMISTRY, 2014, 10 (07) : 641 - 642
  • [50] Viewpoint: Inflammation in cardiovascular disease
    不详
    [J]. CIRCULATION, 2006, 114 (02) : F105 - F105